RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
REGULATION OF CHOLECYSTOKININ SECRETION BY CALCIUM-DEPENDENT CALMODULIN KINASE-II - DIFFERENTIAL-EFFECTS OF PHENYLALANINE AND CAMP
PRPIC, V., BASAVAPPA, S., LIDDLE, RA., & Mangel, A. (1994). REGULATION OF CHOLECYSTOKININ SECRETION BY CALCIUM-DEPENDENT CALMODULIN KINASE-II - DIFFERENTIAL-EFFECTS OF PHENYLALANINE AND CAMP. Biochemical and Biophysical Research Communications, 201(3), 1483-1489.
The release of cholecystokinin was investigated in STC-1 cells, an intestinal cholecystokinin-secreting cell line. Fifteen minute incubation of cells with the amino acid, L-phenylalanine (20 mM), or the phosphodiesterase inhibitor, IBMX (100 mu M), stimulated cholecystokinin secretion. stimulation of secretion by both agents was associated with an increase in cytosolic calcium and was inhibited by the calcium channel blocker, diltiazem (10 mu M). The calcium-calmodulin kinase II inhibitor, KN-62 (1.4 mu M), markedly reduced IBMX-stimulated secretion, but had no effect on phenylalanine-mediated activity. KN-62 also inhibited IBMX-induced increases in cytosolic calcium, suggesting that cAMP may activate diltiazem-sensitive calcium channels by a calmodulin-dependent process. (C) 1994 Academic Press, Inc.